Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
49.9M
-
Shares change
-
+24.9M
-
Total reported value, excl. options
-
$829M
-
Value change
-
+$410M
-
Put/Call ratio
-
1.1
-
Number of buys
-
112
-
Number of sells
-
-36
-
Price
-
$16.62
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q2 2021
163 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q2 2021.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.9M shares
of 127M outstanding shares and own 39.32% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (7.22M shares), BlackRock Inc. (7.02M shares), STATE STREET CORP (4.24M shares), VANGUARD GROUP INC (2.82M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2.11M shares), MORGAN STANLEY (1.85M shares), NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC (1.66M shares), PURA VIDA INVESTMENTS, LLC (1.28M shares), GOLDMAN SACHS GROUP INC (1.15M shares), and MILLENNIUM MANAGEMENT LLC (990K shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.